Synthorx
AcquiredSan Diego, United States · Founded 2014 · $79.0M raised
- Headquarters
- San Diego, California
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- synthorx.com
- Total Funding
- $79.0M
- Last Round
- $63.0M Series CApr 2018
- Rounds
- 3
- Acquired by
- SanofiDec 2019 · $2.5B
About
Synthorx was a La Jolla, California biotechnology company that used synthetic biology and a proprietary expanded DNA alphabet — an engineered base pair beyond the natural A, T, G, and C — to discover and develop novel protein therapeutics, diagnostics, and vaccines. Founded on research from Dr. Floyd Romesberg's lab at The Scripps Research Institute, the company was acquired by Sanofi in December 2019 for $2.5 billion.
Summary
Synthorx is a Biotech company based in San Diego, United States, founded in 2014. It has raised $79.0M in total across 3 rounds, most recently a $63.0M Series C round in Apr 2018. Investors include Avalon Ventures, Sanofi Ventures and OrbiMed.
Funding History
Dec 2019
Sign up to see all 4 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/synthorx"><img src="https://indexed.vc/api/badge/company/synthorx" alt="Synthorx on Indexed.vc" width="260" height="76" /></a>